Antun Sablek is the keynote speaker presenting key research on drivers for pharmaceutical investments globally during the session.
For more information on this event, click here.
Part 4: Inflation Reduction Act: The indirect effects and implications of IRA price negotiations
Since passage of the Inflation Reduction Act (IRA) in August 2022, the focus of many industry analysts and pharmaceutical companies has been on two important...